These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 12578152)
21. The effect of food on the absorption and pharmacokinetics of rivaroxaban. Stampfuss J; Kubitza D; Becka M; Mueck W Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226 [TBL] [Abstract][Full Text] [Related]
22. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials. Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124 [TBL] [Abstract][Full Text] [Related]
23. Telithromycin (HMR 3647) achieves high and sustained concentrations in tonsils of patients undergoing tonsillectomy. Gehanno P; Sultan E; Passot V; Nabet P; Danon J; Romanet P; Attal P Int J Antimicrob Agents; 2003 May; 21(5):441-5. PubMed ID: 12727077 [TBL] [Abstract][Full Text] [Related]
24. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects. Lin TY; Yang MH; Chang FY Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449 [TBL] [Abstract][Full Text] [Related]
25. Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model. Pachot JI; Botham RP; Haegele KD; Hwang K J Pharm Pharm Sci; 2003; 6(1):1-12. PubMed ID: 12753725 [TBL] [Abstract][Full Text] [Related]
26. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers. Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240 [TBL] [Abstract][Full Text] [Related]
27. Lack of significant food effect on the pharmacokinetics of ticagrelor in healthy volunteers. Teng R; Mitchell PD; Butler K J Clin Pharm Ther; 2012 Aug; 37(4):464-8. PubMed ID: 21967645 [TBL] [Abstract][Full Text] [Related]
28. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
29. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin. Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia. Hagberg L; Torres A; van Rensburg D; Leroy B; Rangaraju M; Ruuth E Infection; 2002 Dec; 30(6):378-86. PubMed ID: 12478329 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of telithromycin in community-acquired pneumonia. Van Rensburg DJ; Matthews PA; Leroy B Curr Med Res Opin; 2002; 18(7):397-400. PubMed ID: 12487505 [TBL] [Abstract][Full Text] [Related]
32. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers. Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418 [TBL] [Abstract][Full Text] [Related]
33. Effects of different meal compositions and fasted state on the oral bioavailability of etravirine. Schöller-Gyüre M; Boffito M; Pozniak AL; Leemans R; Kakuda TN; Woodfall B; Vyncke V; Peeters M; Vandermeulen K; Hoetelmans RM Pharmacotherapy; 2008 Oct; 28(10):1215-22. PubMed ID: 18823217 [TBL] [Abstract][Full Text] [Related]
34. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin. Felmingham D J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493 [TBL] [Abstract][Full Text] [Related]
35. Effect of food on the pharmacokinetics and pharmacodynamics of R1663, an oral factor Xa inhibitor, in healthy male volunteers. Schmitt C; Charoin-Pannier A; McIntyre C; Zandt H; Ciorciaro C; Zweigler L; Winters K; Pepper T Int J Clin Pharmacol Ther; 2012 Aug; 50(8):566-72. PubMed ID: 22735461 [TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin. Drusano G Clin Microbiol Infect; 2001; 7 Suppl 3():24-9. PubMed ID: 11523559 [TBL] [Abstract][Full Text] [Related]
37. Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae. Ong CT; Dandekar PK; Sutherland C; Nightingale CH; Nicolau DP Chemotherapy; 2005 Oct; 51(6):339-46. PubMed ID: 16224186 [TBL] [Abstract][Full Text] [Related]
38. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293 [TBL] [Abstract][Full Text] [Related]
39. The effect of food on the absorption of oral ziprasidone. Miceli JJ; Glue P; Alderman J; Wilner K Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Luterman M; Tellier G; Lasko B; Leroy B Ear Nose Throat J; 2003 Aug; 82(8):576-80, 82-4, 586 passim. PubMed ID: 14503094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]